taking

Financing Asia’s Future: IJGlobal’s Infrastructure Finance Forum (IFF): Asia 2025 comes to Singapore

SINGAPORE, Oct. 8, 2025 /PRNewswire/ -- Taking place on 18 & 19 November 2025 at The Westin hotel in Singapore, IFF…

3 months ago

Vantage to Join Forex Expo Dubai 2025 as Elite Sponsor

PORT VILA, Vanuatu, Oct. 4, 2025 /PRNewswire/ -- Vantage Markets is proud to announce its participation in the upcoming Forex Expo…

3 months ago

Yutong Launches EV Long-Life Tech at Busworld Europe 2025, Secures Seven Major Awards

BRUSSELS, Oct. 4, 2025 /PRNewswire/ -- Yutong Bus ("Yutong"; SHA: 600066), a leading global electric bus manufacturer, showcased its electric buses,…

3 months ago

adidas introduced TRIONDA at landmark events in New York, Toronto and Mexico City, with World Cup Legends Jrgen Klinsmann, Cafu, Zinedine Zidane, Alessandro Del Piero and Xavi joining the brand in Brooklyn

The brand officially introduces TRIONDA, the Official Match Ball of FIFA World Cup 26™, at landmark events in New York,…

3 months ago

2026 Kia EV9 Recognized as Cars.Com Top 3Row EV Pick

EV9 took top honors as “Top Pick: 3-Row Electric SUV”Second consecutive year EV9 has been recognizedThe all-electric 2026 Kia EV9…

3 months ago

CCCC Lisbon 2025 Announces Bybit EU and Top Partners as Sponsors of Its Third Global Edition

LISBON, Portugal, Sept. 29, 2025 /PRNewswire/ -- The Crypto Content Creator Campus (CCCC), the global summit at the intersection of…

3 months ago

InboxAlly to Showcase Inbox-First Deliverability at LeadsCon Connect 2025 in Chicago

September 29, 2025 10:00 ET  | Source: InboxAlly New York, NY, Sept. 29, 2025 (GLOBE NEWSWIRE) -- InboxAlly, the award-winning…

3 months ago

Fynd Enters GCC to Power the Region’s Next Wave of Retail Innovation

Fynd opens its first international office in the GCC, establishing its Middle East presence and taking homegrown tech global Fynd…

4 months ago

Patients Taking AUSTEDO XR (deutetrabenazine) extended-release tablets Reported Symptom Improvement and High Satisfaction

Of the 209 patients with tardive dyskinesia (TD) that were surveyed, >94% reported movement improvement once treated with AUSTEDO XR®…

4 months ago

New Long-term Safety Data from the Completed Phase 3 SOLARIS Trial Support the Potential of Olanzapine LAI (TEV-‘749) as the First Long-Acting Olanzapine Treatment Option for Schizophrenia with No PDSS Observed

Through Week 56 in the SOLARIS trial, there were no suspected or confirmed post-injection delirium/sedation syndrome (PDSS) events observed with…

4 months ago